News & Analysis on Clinical Trial Services & Contract Research And Development
News
AI & technology
More→
Promotional features
More→
Streamlining early phase drug development with continuous flow technologies
Paid for and in partnership with Lonza Small Molecules
Achieving data integrity: Best practices for secure and reliable data management
Paid for and content provided by METTLER TOLEDO
AI transforms route scouting for faster drug synthesis
Paid for and in partnership with Lonza Small Molecules
Decentralized clinical trials: The trends, the market and the future
Paid for and content provided by DHL Supply Chain
APIs
More→
AstraZeneca claims phase 3 success with combination therapy for prostate cancer
By Clara Rodriguez Fernandez
Eli Lilly announces positive Phase 2 results for Muvalaplin against heart disease
By Larissa Warneck-Silvestrin
Tirzepatide prevents type 2 diabetes in 99% of prediabetic patients for 3 years
By Clara Rodriguez Fernandez
Contract manufacturing & logistics
More→
Medable and Google Cloud partner to deliver digital clinical trials technology
By Clara Rodriguez Fernandez
Drug delivery & innovation
More→
Verdiva Bio launches with $411m in funding to advance obesity drugs
By Clara Rodriguez Fernandez
Eli Lilly invests $3bn in injectable drug manufacturing facility
By Clara Rodriguez Fernandez
Ingredients
More→
Abbisko’s pimicotinib hits primary endpoint in phase 3 TGCT trial
By Jonathan Smith
FDA grants accelerated approval to Novartis’ Scemblix as a first-line leukemia therapy
By Clara Rodriguez Fernandez
GSK beefs up US manufacturing site with $800 million investment
By Jonathan Smith
Markets & regulatory news
More→
India’s Anthem Biosciences plans $397m IPO
By Jonathan Smith
Gilead recruits Terray in AI-driven drug discovery pact
By Jonathan Smith
AbbVie acquires Roche immune drug spinout in $200 million deal
By Clara Rodriguez Fernandez
Mergers & deals
More→
Mitsubishi teams up with Dewpoint in $480m ALS deal
By Jonathan Smith
Top 5 radiopharmaceuticals startups with VC backing
By Clara Rodriguez Fernandez
Clinical trials & development
More→
Denali Therapeutics’ ALS drug fails to improve function and survival in phase 2/3 trial
By Clara Rodriguez Fernandez
Palatin reports positive phase 2b results in type 2 diabetic nephropathy
By Clara Rodriguez Fernandez
AbbVie’s Parkinson’s disease monotherapy achieves positive phase 3 results
By Larissa Warneck-Silvestrin
